Effect of sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogels on frozen‐thawed human ovarian tissue in a xenograft model
Authors:
- 12 July 2018
- journal article
- research article
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 44 (10) , 1947-1955
Abstract
Aim: Ovarian tissue cryopreservation before cancer treatment is the only option to preserve fertility under some circumstances. However, tissue ischemia after transplantation while awaiting angiogenesis induces dysfunctional folliculogenesis and reduces ovarian reserve and is one of the disadvantages of frozen‐thawed ovarian tissue transplantation. Basic fibroblast growth factor (bFGF) is a major regulator of angiogenesis. However, bFGF rapidly loses biological activity when its free form is injected in vivo. This study investigated whether administration of active bFGF helps establish a nurturing environment for follicular survival.Methods: A sheet form of a sustained release drug delivery system for bFGF was developed using biodegradable acidic gelatin hydrogel (bFGF sheet). The bFGF sheets or phosphate‐buffered saline sheets, as a negative control, were transplanted with frozen‐thawed human ovarian tissues subcutaneously into the backs of severe combined immunodeficient mice. Neovascularization, cell proliferation, fibrosis and follicular survival of ovarian grafts were analyzed at 6 weeks after xenografting.Results: The bFGF sheets were optimized to release bFGF for at least 10 days. The transplantation of bFGF sheets with frozen‐thawed ovarian tissues significantly increased human and mouse CD31‐positive areas and stromal and endothelial cell proliferations. The administration of bFGF also significantly decreased the percentage of the fibrotic area in the graft, resulting in a significant increase in primordial and primary follicular density.Conclusion: Local administration of a sustained release of biologically active bFGF induced neovascularization in frozen‐thawed ovarian tissue grafts, which could establish the nurturing environment required for follicular survival in heterotopic xenografts.Keywords
Funding Information
- Children's Cancer Association of Japan
- Japan Society for the Promotion of Science (JP25462557)
This publication has 42 references indexed in Scilit:
- Fibrin Encapsulation and Vascular Endothelial Growth Factor Delivery Promotes Ovarian Graft Survival in MiceTissue Engineering Part A, 2011
- Both host and graft vessels contribute to revascularization of xenografted human ovarian tissue in a murine modelFertility and Sterility, 2010
- Electron paramagnetic resonance as a tool to evaluate human ovarian tissue reoxygenation after xenograftingFertility and Sterility, 2009
- Long-term ovarian function and fertility after heterotopic autotransplantation of cryobanked human ovarian tissue: 8-year experience in cancer patientsFertility and Sterility, 2009
- A combination of omental flap and growth factor therapy induces arteriogenesis and increases myocardial perfusion in chronic myocardial ischemia: Evolving concept of biologic coronary artery bypass graftingThe Journal of Thoracic and Cardiovascular Surgery, 2006
- Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesisCytokine & Growth Factor Reviews, 2005
- Quantitative assessment of ischemic tissue damage in ovarian cortical tissue with or without antioxidant (ascorbic acid) treatmentFertility and Sterility, 2004
- Gelatin sheet incorporating basic fibroblast growth factor enhances sternal healing after harvesting bilateral internal thoracic arteriesThe Journal of Thoracic and Cardiovascular Surgery, 2003
- Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogelsJournal of Controlled Release, 1994
- The Fate of Intravenously Administered bFGF and the Effect of HeparinGrowth Factors, 1989